Johannes Ettl

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trial”.

Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trial

Annals of Oncology(2020)10.1016/j.annonc.2020.08.2098

N/A

0.899DataRank · unranked

401 citations

Sara A. Hurvitz, Lida A. Mina, Hope S. Rugo, Ki Hoon Lee, Anthony Gonçalvès +15 more

Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer

npj Breast Cancer(2024)10.1038/s41523-024-00667-x

N/A

0.292DataRank · unranked

6 citations

Chunling Hu, Steven N. Hart, Matthias Ruebner, Eric C. Polley, Rohan Gnanaolivu +30 more